Assessment of efficacy and safety of arterolane maleateâpiperaquine phosphate dispersible tablets in comparison with artemether-lumefantrine dispersible tablets in pediatric patients with acute uncomplicated Plasmodium falciparum malaria: A phase 3, randomized, multicenter trial in India and Africa
Clinical Infectious Diseases Sep 01, 2017
Toure OA, et al. – This multicenter (India and Africa), comparative, parallel–group trial was performed to assess the efficacy and safety of arterolane maleate (AM)Âpiperaquine phosphate (PQP) dispersible tablets in comparison with artemether–lumefantrine (AL) dispersible tablets in pediatric patients with acute uncomplicated plasmodium falciparum malaria. Observations revealed that the efficacy and safety of fixed–dose combination of AM and PQP was comparable to AL for the treatment of uncomplicated P. falciparum malaria in pediatric patients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries